Related Experiment Video
Updated: Sep 16, 2025

09:52
Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer
Published on: April 26, 2018
12.7K
Efficient Somatic Cell Nuclear Transfer by Overcoming Both Pre- and Post-Implantation Epigenetic Barriers
Summary
Researchers enhanced mammalian cloning efficiency by combining genetic modifications and treatments to overcome epigenetic barriers in somatic cell nuclear transfer (SCNT) embryos, achieving a 30% full-term development rate.
Area of Science:
- Reproductive Biology
- Epigenetics
- Developmental Biology
Background:
- Somatic cell nuclear transfer (SCNT) for mammalian cloning faces low efficiency due to epigenetic barriers from differentiated somatic cells.
- Two main barriers exist: pre-implantation defects (aberrant gene expression, histone modifications) and post-implantation defects (imprinting errors).
- Current strategies struggle to address both barrier types simultaneously in SCNT embryos.
Purpose of the Study:
- To develop a novel strategy to overcome both pre- and post-implantation epigenetic barriers in SCNT embryos.
- To significantly improve the efficiency of mammalian cloning via SCNT.
Main Methods:
- Overexpression of Kdm4d and Kdm5b, combined with Trichostatin A (TSA) treatment, to resolve pre-implantation epigenetic defects.
- Utilizing tetraploid complementation to bypass post-implantation defects related to extraembryonic lineage and imprinting.
- Assessing full-term development efficiency of reconstructed SCNT embryos.
Main Results:
- The combined strategy successfully overcame epigenetic barriers affecting both pre- and post-implantation development.
- Achieved approximately 30% full-term development efficiency in reconstructed SCNT embryos.
- This represents the highest SCNT efficiency reported in mammals to date.
Conclusions:
- The developed strategy effectively addresses multiple epigenetic barriers in SCNT, significantly enhancing cloning efficiency.
- This breakthrough improves the feasibility and success rate of mammalian cloning.
- The findings pave the way for more efficient applications of SCNT technology.
Related Concept Videos
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Introduction to Nuclear Reprogramming
2.0K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.0K

